IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis-Reference-Cited by-同舟云学术

IFN-γ and CD25 drive distinct pathologic features during hemophagocytic lymphohistiocytosis

Published:2019-06 Issue:6 Volume:143 Page:2215-2226.e7
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Humblet-Baron Stéphanie,Franckaert Dean,Dooley James,Ailal Fatima,Bousfiha Aziz,Deswarte Caroline,Oleaga-Quintas Carmen,Casanova Jean-Laurent,Bustamante Jacinta,Liston Adrian

Funder

VIB

FWO

IUAP

St. Giles Foundation

Jeffrey Modell Foundation

Rockefeller University Center for Clinical and Translational Science

National Center for Research Resources

NCATS

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Rockefeller University

European Research Council

Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence

French National Research Agency

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference40 articles.

1. Hemophagocytic syndromes—an update;Janka;Blood Rev,2014

2. How I treat hemophagocytic lymphohistiocytosis;Jordan;Blood,2011

3. Hemophagocytic lymphohistiocytosis: pathogenesis and treatment;Janka;Hematol Am Soc Hematol Educ Progr,2013

4. Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol;Trottestam;Blood,2011

5. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis;Allen;Hematol Am Soc Hematol Educ Progr,2015

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Directed disruption of IL2 aggregation sites produces designer biologics with enhanced specificity coupled to improved production capacity;2024-09-03

2. Real-world treatment patterns and outcomes in patients with primary hemophagocytic lymphohistiocytosis treated with emapalumab;Blood Advances;2024-05-14

3. Combined emapalumab and ruxolitinib in patients with haemophagocytic Lymphohistiocytosis;Blood Cancer Journal;2024-04-24

4. Case report: emapalumab treatment for a pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) patient with cytokine storm enabling allogeneic hematopoietic cell transplantation;Translational Pediatrics;2024-04

5. Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan;International Journal of Hematology;2024-03-20